---
schema_version: "secwatch.filing_event.v1"
accession: "0001661181-26-000007"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:50:17.889122+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Organogenesis Q1 revenue $36.3M (-58% YoY); net loss $53.2M; FY guidance lowered

## Summary
- Net revenue $36.3M, down 58% YoY from $86.7M; Advanced Wound Care down 63% to $29.5M.
- Net loss $53.2M ($0.44/sh) vs $18.8M loss ($0.17/sh) in Q1 2025; adjusted net loss $43.7M.
- Adjusted EBITDA loss $48.2M vs $12.5M loss; gross margin collapsed to 29% from 73%.
- FY2026 revenue guidance $270M-$310M, decline of 45%-52% from $564.2M in 2025.
- Cash $92.1M, no debt; expects sequential improvement in Q2 and strong H2 growth.

## SEC filing metadata
- accession: 0001661181-26-000007
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000166118126000007/0001661181-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000166118126000007/orgo-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001661181-26-000007
- JSON: https://secwatch.observer/filing/0001661181-26-000007.json
- Plain text: https://secwatch.observer/filing/0001661181-26-000007.txt

## Source-grounded claims
- claim_id: aa0a7801f37d5cdf70b2be15b2aa85c5851b8744
  claim: Organogenesis Holdings Inc. reported first quarter ended March 31, 2026 results: revenue $36.3 million, net income Net loss of $53.2 million, EPS $(0.44) per share. Guidance lowered.
  evidence_excerpt: Net revenue of $36.3 million for the first quarter of 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661181/000166118126000007/0001661181-26-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.